The Effect of Dexmedetomidine on Postoperative Analgesia

This study has been completed.
Sponsor:
Collaborator:
Pharmbio Korea Co., Ltd.
Information provided by (Responsible Party):
Yong Chul Kim, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01373021
First received: June 13, 2011
Last updated: March 6, 2012
Last verified: March 2012

June 13, 2011
March 6, 2012
June 2011
February 2012   (final data collection date for primary outcome measure)
total amount of administered fentanyl [ Time Frame: during first 24 hours after surgery ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01373021 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Effect of Dexmedetomidine on Postoperative Analgesia
Assessment of the Effect of Dexmedetomidine in the Management of Postoperative Pain When Combined With Fentanyl in the Patient-controlled Analgesia

The purpose of this study is to determine whether additional Dexmedetomidine to patient controlled analgesia can reduce fentanyl consumption.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Health Services Research
Colon Cancer, Rectal Cancer
  • Drug: Fentanyl
    Fentanyl 2500mcg+NS50ml
  • Drug: Dexmedetomidine
    Fentanyl 2500mcg+Dexmedetomidine 500mcg + NS 45ml
  • Placebo Comparator: F
    Fentanyl+Normal saline
    Intervention: Drug: Fentanyl
  • Experimental: D
    Fentanyl+Dexmedetomidine
    Intervention: Drug: Dexmedetomidine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
95
February 2012
February 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Elective surgery for colon cancer

Exclusion Criteria:

  • Liver disease
  • Kidney disease
  • Allergy for study drugs
  • Inability to receive patient controlled analgesia
Both
20 Years to 74 Years
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT01373021
sunrud1129
Not Provided
Yong Chul Kim, Seoul National University Hospital
Seoul National University Hospital
Pharmbio Korea Co., Ltd.
Not Provided
Seoul National University Hospital
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP